December 18, 2023 by Jeffrey Woldt
CVS Health, Jeffrey Woldt, Karen Lynch
2023, Issue 12-18-2023, Opinion
CVS Health is once again a catalyst for positive change. Appearing at the company’s investor day earlier this month, CEO Karen Lynch and other members of senior management unveiled initiatives intended to accelerate the shift toward integrated care and transform the pharmacy reimbursement model. One of the projects involves the creation of a new brand
December 4, 2023 by Jeffrey Woldt
2023 Health Equity Summit, Chain Drug Review, Chain Drug Review/MMR Video Forum, Kearney
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Kearney’s Laura Bowen and Karen Yocky talk about what the consulting firm has learned from its work in helping clients step up the fight against health disparities. They spoke during the second-annual Health Equity Summit sponsored by Kearney and Chain Drug Review.
November 27, 2023 by Jeffrey Woldt
FMI, Jeffrey Woldt, Leslie Sarasin, opinion
Issue 11-27-2023
Leslie Sarasin takes an expansive view of her work. As president and chief executive officer of FMI – The Food Industry Association, she has significantly broadened the organization’s reach, carving out a bigger role within FMI for grocery manufacturers and other industry stakeholders, while at the same time forging partnerships with groups that support its
November 27, 2023 by Jeffrey Woldt
Chain Drug Review/MMR Video Forum, ECRM, Sarah Davidson, Video Forum
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Sarah Davidson, executive vice president at ECRM, reflects on the company’s upcoming 30th anniversary in 2024. She discusses the evolution of ECRM over the course of the three decades since it was founded by Charlie Bowlus and — after the pandemic necessitated a shift to virtual sessions — plans to
November 13, 2023 by Jeffrey Woldt
Chain Drug Review, Haleon, Lisa Paley, Scott Emerson, The Emerson Group
Featured Articles, Leading Headlines, Videos
The industry will soon come together to recognize the National Association of Chain Drug Stores for its myriad contributions to retailing and health care over the past nine decades. Scott Emerson, founder and CEO of the Emerson Group, and Lisa Paley, president of Haleon’s North American business, talk about plans for the event and how
November 7, 2023 by Jeffrey Woldt
2023 Heath Equity Summit, Chain Drug Review, Hy-Vee, Kearney, Kristin Williams, Part 1
Featured Articles, Leading Headlines, Videos
Chain Drug Review and Kearney recently assembled a group of leading pharmacy operators and other retailers, physicians, payers, public officials, and policy experts for the second-annual Health Equity Summit in Chicago. This installment of Video Forum is the first in a series that will present highlights from the event. Here are excerpts from remarks by
October 16, 2023 by Jeffrey Woldt
Amazon Pharmacy, Chain Drug Review/MMR Video Forum, Dr. Vin Gupta, Video Forum, Vin Gupta
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Dr. Vin Gupta, Amazon Pharmacy’s chief medical officer, talks about the potential for e-commerce providers to help bring down the cost of prescription medications. In addition to outlining various ways in which Amazon is trying to do just that, Gupta responds to those who contend that online pharmacies can’t provide
October 9, 2023 by Jeffrey Woldt
Jeffrey Woldt, Sam's Club
Issue 10-09-2023, Opinion
Sam’s Club has changed considerably in 40 years. As the special section elsewhere in this issue amply illustrates, the retailer, a division of Walmart, has found numerous ways to enhance the membership warehouse club format, while adhering to the fundamentals of the concept. When Sam’s made its debut In 1983, the bare-bones clubs sold a
September 25, 2023 by Jeffrey Woldt
Chain Drug Review/MMR Video Forum, community pharmacies, health care, Pano Anthos, Video Forum, XRC Ventures
Featured Articles, Leading Headlines, Videos
Pano Anthos, founder and managing director of XRC Ventures, tells this week’s Video Forum about how innovations by emerging technology companies will help make community pharmacies the first line of defense in health care. He also discusses the pace of change in technology, health care and retailing, as well as the attitude of consumers toward
September 22, 2023 by Dominique Harris, Karen Yocky and Jeffrey Woldt
Chain Drug Review, Health Equity Summit, Kearney
Featured Articles, Leading Headlines, Retail News, Topics
The health care ecosystem faces major challenges — how to enhance health outcomes through more equitable access to care, while addressing rising costs. Part of the answer is improving health equity, a task that will require collaboration across the value chain. The second annual Health Equity Summit – presented by Chain Drug Review and Kearney,
September 18, 2023 by Jeffrey Woldt
Chain Drug Review/MMR Video Forum, Pano Anthos, Video Forum, XRC Ventures
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries. He discusses XRC’s investment strategy, the criteria it uses to decide which start-up and early-stage companies to work with, and the sectors that he sees as
September 11, 2023 by Jeffrey Woldt
Jeffrey Woldt, PBM
Issue 09-11-2023, Issues
Value-based care is coming to the PBM sector. Blue Shield of California last month launched a program that eschews the entrenched pharmacy benefits management model, replacing it with a consortium of companies — which includes Amazon Pharmacy and Mark Cuban Cost Plus Drug Co. — assembled to change the way prescription drugs are purchased and